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ABSTRACT 25 
Cyathostomins are the most prevalent parasitic pathogens of equids worldwide.  These 26 
nematodes have been controlled using broad-spectrum anthelmintics; however, cyathostomin 27 
resistance to each anthelmintic class has been reported and populations insensitive to more 28 
than one class are relatively commonplace.  The faecal egg count reduction test (FECRT) is 29 
considered the most suitable method for screening anthelmintic sensitivity in horses, but is 30 
subject to variation and is relatively time-consuming to perform.  Here, we describe a larval 31 
migration inhibition test (LMIT) to assess ivermectin (IVM) sensitivity in cyathostomin 32 
populations.  This test measures the paralysing effect of IVM on the ability of third stage 33 
larvae (L3) to migrate through a pore mesh.  When L3 from a single faecal sample were 34 
examined on multiple occasions, variation in migration was observed: this was associated 35 
with the length of time that the L3 had been stored before testing but the association was not 36 
significant.  Half maximal effective concentration (EC50) values were then obtained for 37 
cyathostomin L3 from six populations of horses or donkeys that showed varying sensitivity 38 
to IVM in previous FECRTs.  Larvae from populations indicated as IVM resistant by FECRT 39 
displayed significantly higher EC50 values in the LMIT than L3 from populations classified 40 
as IVM sensitive or L3 from populations that had not been previously exposed to IVM or had 41 
limited prior exposure.  The analysis also showed that EC50 values obtained using L3 from 42 
animals in which IVM faecal egg count reduction (FECR) levels had been recorded as <95% 43 
were significantly higher than EC50 values obtained using L3 from animals for which FECR 44 
was measured as >95%.  For one of the populations, time that had elapsed since IVM 45 
administration had an effect on the EC50 value obtained, with a longer time since treatment 46 
associated with lower EC50 values.  These results indicate that the LMIT has value in 47 
discriminating IVM sensitivity amongst cyathostomin populations, but several factors were 48 
identified that need to be taken into account when executing the test and interpreting the 49 
derived data.  50 
51 
 3 
1. Introduction 52 
Cyathostomins are highly prevalent and potentially pathogenic parasitic nematodes found in 53 
the large intestine of horses and other equids worldwide. The cyathostomin group comprises 54 
around 50 species (Lichtenfels et al., 2008); however, little is known of the ecology of the 55 
individual species or how they interact with one another in the host or in external environment.  56 
Anthelmintic resistance (AR) is a major issue in this group of nematodes: resistance to 57 
benzimidazoles (BZ) is widespread and, in some areas, resistance to pyrantel, a member of the 58 
tetrahydropyrimidine (THP) class, is highly prevalent (Kaplan, 2002).  Reduced sensitivity to 59 
the macrocyclic lactone (ML) anthelmintics, ivermectin (IVM) and moxidectin (MOX), has also 60 
been recorded in cyathostomin populations (Trawford et al., 2005; Trawford and Burden, 2009; 61 
Molento et al., 2008; Traversa et al., 2012; Relf et al., 2014).  Multi-class resistance in single 62 
populations to BZ and THP class anthelmintics is also commonly reported (Kaplan et al., 2004; 63 
Canever et al., 2013; Lester et al., 2013).  As no new anthelmintic classes are being developed 64 
for use in horses in the short to medium term, and reversion to anthelmintic sensitivity does not 65 
seem to readily occur in resistant nematode populations (Jackson and Coop, 2000), it is essential 66 
to preserve efficacy of the currently effective products.  For these reasons, tests that facilitate 67 
decisions regarding anthelmintic treatment in horses will play an increasingly important role in 68 
control (Matthews, 2014).  In this context, it is important to identify AR as soon as practically 69 
possible so that measures can be taken to prevent its spread (Tandon and Kaplan, 2004).  The 70 
faecal egg count reduction test (FECRT) is currently the ‘gold standard’ non-invasive test for 71 
assessing anthelmintic efficacy in horses (Vidyashankar et al., 2012).  This test is relatively 72 
labour intensive to implement: faecal samples for analysis need to be obtained on at least two 73 
occasions and it is often a challenge to obtain adequate numbers of horses with a faecal egg 74 
count (FEC) of sufficient magnitude to perform the test with high accuracy.  The non-uniform 75 
distribution of eggs within and between faecal samples further complicates data analysis 76 
(Denwood et al., 2010).  For these reasons, AR detection methods that are more efficient to 77 
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perform and subject to less variability need to be investigated.  For cyathostomins, such tests 78 
should focus on ML anthelmintics.  This is because these products hold the major market-share 79 
worldwide and, as the prevalence of ML resistance is currently less advanced than with BZ and 80 
THP anthelmintics (Molento et al., 2012), and hence tests that inform on sensitivity to ML are 81 
likely to have most impact on mitigating the spread of resistance.  Molecular mechanisms 82 
leading to ML resistance in cyathostomins remain to be defined, so there are no molecular tests 83 
available, leaving bench-based in vitro tests as the remaining option.   84 
The larval development test has been investigated for measuring anthelmintic sensitivity in 85 
cyathostomins; however, this test has not proven particularly informative in defining ML 86 
sensitivity levels (Tandon and Kaplan, 2004; Lind et al., 2005; Matthews et al., 2012).  An 87 
alternative test that has been investigated for assessing anthelmintic sensitivity in ruminant 88 
nematode (Demeler et al., 2010; 2012; 2013) and in cyathostomin (van Doorn et al., 2010) 89 
populations is the larval migration inhibition test (LMIT).  Here, we assessed the potential of the 90 
LMIT for measuring IVM sensitivity in cyathostomin larvae derived from different equine 91 
populations.  This test was deemed appropriate for purpose because the major targets of IVM 92 
are ligand-gated chloride channels, which, when bound, result in nematode paralysis (Shoop et 93 
al., 1995) and hence will affect the ability of larvae to migrate through small pores of a filter.  94 
The cyathostomin populations examined in the current study were derived from groups of 95 
donkeys demonstrated previously, by FECRT, to exhibit differing levels of sensitivity to IVM in 96 
vivo (Trawford and Burden, 2009), or from equids administered with minimal or no ML 97 
treatments (Wood et al., 2013).  The proportion of L3 that migrated through a pore filter at 98 
increasing concentrations of IVM were measured and the data compared amongst individual 99 
equids and between populations to inform on the value of this test.   100 
 101 
 102 
 103 
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2. Materials and methods 104 
 105 
2.1. Populations 106 
Parasites from six equine populations were used: four consisted of donkeys and two of 107 
ponies.  Three donkey herds (Populations A-C) were based at the UK Donkey Sanctuary 108 
(Devon, England, UK).  The three populations were grazed separately on geographically 109 
distinct farms.  Donkeys in Populations A and B had been demonstrated previously, by 110 
FECRT, to harbour cyathostomins that exhibited reduced sensitivity to IVM and MOX 111 
(Table 1, Trawford et al., 2005; Trawford and Burden, 2009).  In Population C, the 112 
cyathostomins were deemed IVM sensitive as indicated by the finding of a mean FECR of 113 
>95% in treated animals 14 days after IVM administration (Table 1); however, the strongyle 114 
egg reappearance period for some of the donkeys in this population was below the standard 115 
egg suppression period of IVM and MOX (F. Burden, pers comm.), described previously as 8 116 
weeks (Lyons et al., 1992, Bello, 1996) and 13 weeks (DiPietro et al., 1997), respectively.  117 
These observations are generally accepted as an early indicator of AR (Molento et al., 2012).  118 
In all three Donkey Sanctuary populations, IVM or MOX subcutaneous injection 119 
preparations registered for use in cattle had previously been administered orally (F. Burden, 120 
pers comm.).  This may have predisposed the nematodes in these populations to reduced 121 
sensitivity to ML anthelmintics.  Population D comprised a privately owned herd of donkeys 122 
grazed in Cheshire, UK.  These donkeys had not received IVM in the 5 years preceding this 123 
study and had only received MOX and anti-cestode treatments during this time.  No 124 
anthelmintic had been administered in the preceding 12 months.  As part of this study, 125 
Population D was subjected to an IVM FECRT following World Association for the 126 
Advancement of Veterinary Parasitology guidelines (Coles et al., 1992) using a double 127 
centrifugation FEC technique sensitive down to 1 egg per gram (Christie and Jackson, 1982).  128 
In Population D, IVM FECR was found to be 100% in all donkeys tested.  Populations E and 129 
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F comprised two groups of ponies used for conservation purposes in the Fens of East Anglia, 130 
South East England (Wood et al., 2013).  Population E comprised Dartmoor ponies grazed on 131 
grassland fen.  At the start of the study, all ponies had grazed the Fens for two years.  During 132 
this time, these ponies were not administered with ML products.  Population F consisted of 133 
Konik ponies grazed on grassland fen since the mid-1990s.  These animals did not receive 134 
ML products during this time and were unlikely to have ever received this class of 135 
anthelmintic.  Due to potential eco-toxicological risks (McKellar, 1997), IVM FECRT were 136 
not performed at the sites grazed by Populations E and F, as the use of ML products is not 137 
permitted.  Given the lack of ML treatments in these populations, it is assumed that the 138 
resident cyathostomins in Populations E and F are highly sensitive to IVM and MOX.     139 
 140 
2.2. Preparation of third stage larvae for LMIT analysis 141 
Freshly voided faecal samples were collected from identified individuals and immediately 142 
placed into labelled plastic bags, which were sealed to exclude as much air as possible to 143 
retain anaerobic conditions.  All samples were sent on the day of collection.  Each sample 144 
was weighed, homogenised thoroughly and a 10 g sub-sample removed for FEC analysis 145 
(Christie and Jackson, 1982).  The remainder was cultured under aerobic conditions by 146 
transferring faeces to plastic trays, which were placed inside perforated plastic bags.  Faeces 147 
were incubated at 15oC for up to 22 days, after which, the trays were flooded with lukewarm 148 
tap water for 4 h.  The supernatants, containing strongyle L3, were poured over a Baermann 149 
filter (MAFF, 1986) and the filter placed in the neck of a jam jar filled with tap water.  The 150 
filter was left overnight, removed the next morning and the remaining volume reduced to 20 151 
ml.  The L3 were transferred to culture flasks and enumerated in 10 x 10 µl aliquots and 152 
classified as small or large strongyle L3 on the basis of gut cell morphology (Thienpont et al., 153 
1986).  No large strongyles were observed in any samples from Populations A-E.  Very low 154 
numbers of large strongyle larvae (<1%) were observed in samples from Population F.  A 155 
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complete lack of ivermectin or moxidectin treatments in Population F are likely to explain 156 
why this was the only population that was identified as positive for large strongyle larvae. 157 
The L3 were stored in tap water in vented flasks at 4oC at a maximum concentration of 2,500 158 
L3 ml-1 for up to 60 days.  At this time point, viable L3, as assessed by motility and the 159 
presence of intact gut cells, were observed.  The water was replenished weekly. 160 
 161 
2.3. Larval migration inhibition test 162 
The LMIT described here is an adaptation of the method developed for assessing 163 
anthelmintic sensitivity of ruminant nematode L3 by Demeler et al. (2010; 2012; 2013).  This 164 
protocol utilises a migration system that enables physical separation of motile from non-165 
motile L3 through a filter mesh (Nytal mesh).  The pore diameter allows active larvae, but 166 
not dead larvae, to pass through the mesh.  For each test, approximately 2,500 L3 were 167 
removed from each culture derived from an individual animal.  The L3 were exsheathed in 168 
700 µl, 2% w/v sodium hypochlorite solution for 3.5 min at room temperature and washed 169 
thoroughly three times by centrifugation for 2 min at 203 x g in phosphate buffered saline, 170 
pH 7.4 (PBS: 150 mM sodium chloride, 150 mM sodium phosphate).  Exsheathed L3 were 171 
subjected to Baermannisation for 2 h at 26oC immediately before the test was run.  The L3 172 
were collected by centrifugation, recounted and re-suspended in 1,200 µl PBS.  As IVM had 173 
to be dissolved in 100% dimethyl sulphoxide (DMSO) for the test, the effect of DMSO on L3 174 
motility was tested over a range of concentrations (0, 5, 6, 7, 8, 9, 10% w/v DMSO/PBS).  175 
Each dilution was assessed in duplicate using L3 from Population C and the experiment 176 
repeated on three occasions.  The derived data indicated that 5% DMSO w/v PBS was the 177 
highest concentration at which < 2% adverse effect was observed on migration compared to 178 
PBS-only control wells (data not shown).  The impact of the diameter of the pores within the 179 
mesh was then assessed.  This was performed by killing the L3 by incubation at 70oC for 20 180 
min, then adding them in PBS-only or 5% DMSO w/v PBS to the upper side of filters of pore 181 
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diameter 25 and 28 µm.  After 2 h, the underside of the filters was examined to assess if L3 182 
‘fell through’ by gravity: L3 were not observed on the underside of filters of pore diameter 25 183 
µm or 28 µm.  Subsequently, 25 µm pore diameter filters were selected for use in the test.  184 
For assessment of the effect of IVM on L3 migration, analytical grade IVM (Sigma Aldrich, 185 
cat. no: I8898) was dissolved in 100% DMSO to give a stock solution of 3,000 µgml-1 IVM.  186 
Before each batch of tests, this stock was serially diluted in PBS/DMSO to give working 187 
dilutions of 5, 20, 60, 300, 3,000 µgml-1 IVM/5% DMSO w/v PBS (final molarity used in the 188 
test ranged from 1.12 x10-5 - 6.73 x 10-3 M).  In all tests, L3 migration was assessed in a 189 
positive control well containing only 5% DMSO w/v PBS and IVM test concentrations and 190 
controls were set up in duplicate (approximately 100 L3 analysed per well).  The L3 were 191 
pre-incubated at 26oC for 2 h in the dark in 10 µl IVM at each test concentration in 5% 192 
DMSO w/v PBS.  After this, L3 in IVM solution were transferred to the upper side of filters 193 
in corresponding duplicate wells on a migration plate, containing 1,910 µl of each test 194 
concentration.  The samples were incubated for 2 h at 26°C in the dark.  After this, migration 195 
chambers were lifted out and 600 µl PBS used to wash the outside of the chambers so that 196 
any adhering (but migrated) L3 were washed into the corresponding well.  The upper 197 
chamber was inverted and, using 2 x 1,000 µl PBS, L3 that had not migrated were washed 198 
into the corresponding well in the row below.  The effect of IVM on the ability of the L3 to 199 
migrate through the mesh pores was confirmed by observations, prior to fixing, that the 200 
worms that had come through the mesh were motile and moving in classical sinusoidal 201 
movements, whilst those retained above the mesh moved slowly or not at all, or assumed 202 
angular postures and performed jerky movements of the head and tail regions.  The L3 were 203 
fixed with 200 µl, 100% molecular grade ethanol and migrated and non-migrated L3 204 
enumerated at x100 magnification using an inverted stereomicroscope.  To study 205 
repeatability of the test and the potential effect of L3 storage time on migration in the LMIT, 206 
L3 derived from a single culture from a donkey in Population B were analysed on seven 207 
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separate occasions.  This donkey had not received IVM in the 780 days preceding sample 208 
collection.  The test was run using L3 that had been stored from 22 to 55 days at 4oC.  209 
Finally, to compare the value of the LMIT in defining IVM sensitivity among cyathostomin 210 
populations of varying sensitivity to the anthelmintic in vivo, L3 derived from single time 211 
point faecal samples from each Population: A (n=4), B (n=5), C (n=6), D (n=5), E (n=6) and 212 
F (n=6) were assessed.  All samples were tested at each IVM concentration in duplicate. Only 213 
when (un-scaled) mean migration of the L3 in the two positive control wells exceeded 70%, 214 
was migration in the presence of IVM subjected to further data analysis.  215 
 216 
2.4. Statistical analysis and modelling    217 
For data analysis, the percentage migration was calculated for each replicate, with 218 
migration in the PBS/DMSO-only well scaled to 100%.  For data exploration, dose-response 219 
curves (DRC) of the proportion of L3 migrating versus Log10(IVM conc + 0.01) were 220 
plotted for each sample.  The small additive component, 0.01, allowed the inclusion of data at 221 
zero IVM concentration and was found empirically to have minimal impact on estimated 222 
EC50 values.  The DRC were statistically modelled using a four-parameter logistic dose 223 
response model on the natural logarithm of IVM concentration (Demeler et al., 2010; 2012) 224 
permitting estimation of EC50.  Summary EC50 values were compared using the Kruskal 225 
Wallis test with post-hoc analysis using the method of Siegel and Castellan (1988).  The 226 
association between EC50 and time since last IVM treatment was tested with a linear model 227 
predicting EC50 from time since last IVM treatment and population membership.  DRC 228 
modelling, hypothesis testing and post-hoc analysis were preformed in the R statistical 229 
system (R Development Core Team, 2012) using the packages “drc”, “lme4” and “pgirmess”. 230 
 231 
 232 
 233 
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3. Results 234 
 235 
3.1. Value of the LMIT results in defining IVM sensitivity amongst cyathostomin populations 236 
When the test was run on seven occasions on different days using L3 derived from a 237 
single donkey, it was found that L3 stored for shorter periods in culture generally exhibited 238 
higher migration in the presence of IVM, but the differences observed between storage time 239 
points were not significant. The L3 migration values were then compared amongst the six 240 
cyathostomin populations.  The percentage of times that < 70% migration in the control wells 241 
was observed was 10%.  When < 70% migration was observed, the test was repeated with L3 242 
from the same individual; however, < 70% migration was achieved in all subsequent tests 243 
with these samples, so the LMIT data from these L3 were not used in subsequent analyses 244 
and are not included in the numbers quoted for each equid population, above.  The range of 245 
EC50 values obtained for each population (A-F) is shown in Table 2 and the derived DRC’s 246 
are depicted in Figure 1.  Resistance ratios were generated by dividing single EC50 estimates 247 
from data for each Population (A-E) by the EC50 value obtained from data from Population 248 
F (Table 2).  Highest EC50 values were obtained using cyathostomin L3 from populations A 249 
and B, which had been demonstrated to be resistant to IVM in vivo.  The next highest EC50 250 
value was obtained using L3 from the population for which a reduced ERP had been 251 
demonstrated following IVM and MOX treatment (Population C).  Lower EC50 values were 252 
obtained using L3 from populations shown to be sensitive to IVM by FECRT (Population D) 253 
or populations in which IVM treatments had been minimal or non-existent (Populations E 254 
and F).   255 
The predictive value of the LMIT for assessing relative IVM sensitivity was further 256 
considered by comparing EC50 values obtained using L3 derived from populations 257 
demonstrated to be IVM resistant (IVM-R) on the basis of mean FECR <95% after IVM 258 
treatment (Populations A and B), with those values obtained using L3 from the population 259 
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(C) for which the mean FECR was reported as >95%, but the ERP was reduced following 260 
IVM administration (IVM-RERP), and with populations that were highly sensitive to IVM 261 
(i.e. FECR 100%) or had received no IVM treatments (Populations D, E and F), combined 262 
here as IVM-sensitive (IVM-S, Figure 2).  The data analysis indicated that EC50 values 263 
obtained with IVM-R L3 were significantly higher than EC50 values obtained using IVM-S 264 
L3 (p < 0.05), but not the EC50 values obtained using IVM-RERP L3.  In addition, EC50 265 
values obtained using L3 from the IVM-RERP population were significantly higher than 266 
those obtained with L3 from the IVM-S populations (p < 0.05).   267 
 268 
3.2. Association between derived EC50 values and data derived from IVM-FECRT results in 269 
individual animals 270 
EC50 values obtained using L3 from Populations A, B and C  (i.e. those populations that 271 
had been subjected previously to IVM FECRT analysis) were used to investigate the 272 
hypothesis that there would be a negative association between the percentage reduction in 273 
FEC observed 2 weeks after IVM administration and the EC50 values obtained in the IVM-274 
LMIT (Figure 3).  The analysis indicated that there is indeed a relationship, with individuals 275 
measured as having a FECR of >95% having lower EC50 values in the IVM-LMIT than 276 
those for which FECR was <95% (two-way ANOVA, EC50 and FECR>95%, p(FECR) 277 
p=0.000284).  278 
 279 
3.3. Analysis of IVM sensitivity in single populations over time since last IVM treatment 280 
The EC50 values obtained using L3 from Populations A, B and C (i.e. those populations 281 
that had a relatively recent IVM treatment) were used to examine if there was a relationship 282 
between the proportion of L3 that migrated in the presence of IVM with the number of days 283 
since the last recorded IVM administration (Figure 4).  The time since IVM treatment for 284 
each population ranged as follows: Population A (n=4) – 40-102 days (mean, 57.5 days), 285 
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Population B (n=5) – 41-780 days (mean, 250.25 days), and Population C (n=5, one animal 286 
of the original 6 animals was not treated with IVM) – 65-194 days (mean, 143.50 days).  The 287 
analysis indicated that there is a relationship, with higher proportions of migration observed 288 
with L3 derived from samples obtained nearer to IVM treatment: i.e. the EC50 value 289 
obtained was negatively associated with time since last IVM treatment.  This association was 290 
significant in the case of the L3 that were derived from Population C (p=0.028)  291 
 292 
4. Discussion 293 
 294 
Macrocyclic lactone anthelmintics, such as IVM, that paralyse nematode somatic muscles, 295 
among other modes of action, have been assessed in vitro via their effect on larval motility or 296 
migration.  Such tests are potential options for detecting anthelmintic resistance because they 297 
are cheap, relatively quick to perform, preclude host influences and, as they can be run over a 298 
concentration range, may provide reproducible parameters with which to measure phenotype 299 
(Demeler et al., 2013).  Several studies utilising ruminant parasitic nematodes have indicated 300 
that motility and migration tests are useful tools for informing on the ML sensitivity of single 301 
species populations (Martin and Le Jambre, 1979; Folz et al., 1987; Sangster et al., 1988; 302 
Demeler et al., 2010, 2012, 2013).  Here, we examined the value of the LMIT for use with 303 
cyathostomin larvae obtained by culture from equine faeces.  We assessed utility of the test 304 
for informing on IVM sensitivity of cyathostomins obtained from populations for which 305 
FECRT data was available or populations in which IVM treatments had not been applied or 306 
had been limited. Here, we used cyathostomin larvae from donkeys in a comparison with 307 
larvae derived from horses because it is problematic to obtain populations of small strongyles 308 
from horses for which an IVM FECR of <95% has been demonstrated.  For example, 309 
shortened IVM ERP has been identified several times in cyathostomins in horse populations 310 
(for example, Relf et al., 2013), but populations exhibiting a mean FECR of less than 95% 311 
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have been reported only sporadically in horses and primarily in South America (Canever et 312 
al., 2013).  In our comparisons, the LMIT was found to discriminate IVM sensitivity amongst 313 
cyathostomin populations in agreement with results that had been previously generated using 314 
the FECRT.  For example, the derived EC50 values obtained with L3 from IVM-R 315 
(Populations A and B) and IVM-RERP (Population C) populations were significantly higher 316 
than EC50 values obtained using L3 from all IVM-S populations (D, E and F).  These results 317 
concur with studies on Haemonchus contortus, where correlations were identified between 318 
the results of the LMIT and the in vivo anthelmintic resistance status (Gill and Lacey, 1998).  319 
In the Haemonchus study, the association was found to vary depending on how the nematode 320 
strains were selected, with no correlations found when using strains that had been selected 321 
experimentally using sub-optimal doses of anthelmintic.  In agreement with the current study, 322 
though, good correlations between migration in the test and the results of prior FECRT 323 
analysis were found when resistant strains isolated from the field (i.e. selected with 324 
therapeutic doses of anthelmintic) were compared.   325 
One observation from the current study was that although there was a significant 326 
difference observed in EC50 values between IVM-R or IVM-RERP and IVM-S populations, 327 
there was variation within each population in the EC50 value obtained using L3 derived from 328 
individual animals (Table 2).  This was particularly noticeable in the IVM-R isolates.  329 
Although this concurs with variation in ML FECR levels obtained by FECRT in the IVM 330 
resistant populations here, this level of variability could affect the value of this test if pooled 331 
samples were to be assessed from a given population in the field, where it could be 332 
impractical to run the test on many individuals.  Two further confounding factors were 333 
identified.  One of these was the length of time that L3 had been stored in the laboratory 334 
before the test.  An effect of culture age on migration was observed, even though L3 were 335 
Baermannised just prior to running the test.  In previous publications using ruminant 336 
nematode larvae, the effect of L3 storage time was not detailed: for example, Demeler et al. 337 
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(2010) used L3 from sheep faecal cultures stored for ‘up to 3 months’, but the impact of 338 
culture period was not specifically addressed.  Other studies (for example, Sangster et al., 339 
1988) do not mention the length of time that L3 were stored for prior to use in the LMIT.  In 340 
others, the effect of L3 storage time has been assessed: for example, using the LMIT, Molan 341 
et al. (2000) compared the sensitivity to condensed tannins of Trichostrongylus colubriformis 342 
larvae stored for 1 month versus larvae stored for 7 months.  Similar to the findings here, 343 
these authors found that the T. colubriformis L3 stored for longer periods in the laboratory 344 
were more sensitive to the xenobiotic tested than larvae stored for shorter periods (p<0.001).  345 
The differences observed in the current study were not significant; however, larvae were 346 
stored up to only 55 days as opposed to 7 months. On the basis of the results here and the 347 
observations made in other nematode species, it is recommended that L3 be used as fresh as 348 
possible when assessing IVM sensitivity in the LMIT.   349 
The analysis also indicated that the time that elapsed between last IVM treatment and 350 
when the faecal samples were obtained for processing had an effect on the derived EC50 351 
values in the LMIT.  The effect was only found to be significant for Population C: this may 352 
have been because this population had the widest range in days since last IVM treatment in 353 
the donkeys that were selected for supply of L3 for the LMIT.  This observation could be 354 
explained by the fact that the nearer to IVM treatment that the L3 are tested in the LMIT, the 355 
more likely it is that the parasites used are derived from nematodes that may have survived 356 
treatment.  This is particularly problematical to investigate in cyathostomins because the 357 
exact length of the life cycle of different individual species is unknown and these parasites 358 
can undergo a variable period of encystment in the large intestinal wall (Love et al., 1999).  359 
Because of the effect of time since last anthelmintic treatment observed here, it is 360 
recommended that the impact of this parameter be assessed further in future.  361 
Despite these various caveats, the results here showed clear differences in EC50 values 362 
measured amongst the cyathostomin populations that were tested. This was observed even 363 
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although the L3 samples tested were likely to comprise mixed cyathostomin species.  It has 364 
been indicated in preliminary studies that different cyathostomin species may vary in their 365 
sensitivity to IVM in the LMIT (van Doorn et al., 2010).  Also, in ruminant nematode studies 366 
it has been observed that different species differ in ML sensitivity in the LMIT, which cannot 367 
always be predicted from their relative sensitivity to MLs in vivo (Demeler et al., 2012).  In 368 
the van Doorn et al., (2010) study, where cyathostomin L3 were rendered more tolerant in 369 
vitro though iterative selection by several cycles of migration in the presence of IVM, it was 370 
identified that Cyathostomin catinatum became the predominant species in the two 371 
populations that were tested.  Furthermore, cyathostomin species composition in donkeys can 372 
be different from species composition in horses (Matthee et al., 2004).  For these reasons, the 373 
authors will now examine the species of cyathostomin present in these populations using L3 374 
recovered from the LMIT utilising species specific DNA probes that they have developed 375 
based on intergenic spacer region nucleotide sequences (Cwiklinski et al., 2012).  376 
Although the results here indicate that the LMIT has value in providing information on the 377 
IVM sensitivity status of a cyathostomin population, it cannot be assumed that the 378 
‘resistance’ mechanisms that affect the ability of the L3 to migrate in the LMIT are the same 379 
as those present in parasitic stages that operate to allow these stages to survive treatment in 380 
the host.  As such, the LMIT provides only a gauge on the relative IVM sensitivity of a 381 
population. There is some indication from the work of van Doorn et al., (2010), that the 382 
mechanism at play in the LMIT involves glutamate, but this requires further study.  Despite 383 
the aforementioned limitations, significant differences in LMIT EC50 values were observed 384 
here between cyathostomin larvae derived from IVM-R or IVM-RERP populations and 385 
larvae obtained from populations that were shown to be, or assumed to be, IVM sensitive.  386 
Moreover, at the individual equid level, a direct correlation was identified between the 387 
percentage reduction in FEC measured in vivo using the IVM-FECRT and the LMIT EC50 388 
value obtained using L3 from the same animal.  The parasite isolates used here may be at the 389 
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extremes of IVM sensitivity and resistance (as indicated by the high resistance ratios 390 
generated for populations A and B when compared to population F) than may be found 391 
generally, and work now needs to be performed using samples derived from a wider range of 392 
populations for which the in vivo resistance phenotype is not so obvious, for example, 393 
cyathostomin populations for which IVM FECR is > 95% but the strongyle ERP is reduced.   394 
 395 
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 523 
Table 1.  Details of the equid populations used to provide L3 for the larval migration 524 
inhibition test and their relative sensitivity to ivermectin as indicated by faecal egg count 525 
reduction tests. Details for population moxidectin sensitivity is also indicated where the data 526 
is available.  ML; macrocyclic lactone, IVM; ivermectin, MOX; moxidectin, ERP; egg 527 
reappearance period, FECR; faecal egg count reduction, L3; third stage larvae.  528 
 529 
Population 
name 
Host 
species 
Location ML sensitivity or 
treatment 
history 
 
Mean IVM-FECR 
measured in population 
from which L3 samples 
were derived1 
(lower confidence 
limits) 
A Donkey South west 
England 
IVM resistant 
[MOX resistant] 
91% (0%) 
B Donkey South west 
England 
IVM resistant 
[MOX resistant] 
82% (0%) 
C Donkey South west 
England 
IVM reduced ERP 
[MOX reduced ERP] 
>95% (>90%) 
D Donkey North west 
England 
IVM sensitive 100% 
 
E Horse South east 
England 
No ML in last 2 
years 
ND2 
 
F Horse South east 
England 
ML not administered ND2 
 
 530 
 531 
1 Where indicated, resident nematode populations were tested for ivermectin sensitivity using a faecal 532 
egg count reduction test (FECRT) method based on World Association for the Advancement of 533 
Veterinary Parasitology guidelines for ruminants (Coles et al. 1992). The mean reduction in faecal 534 
egg count at 14 days after administration is indicated here. 2 FECRT not performed, as macrocyclic 535 
lactone use was not permitted as the horses are graze on natural conservation sites.  536 
 537 
 538 
 539 
  540 
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Table 2. EC50 value ranges obtained in the larval migration inhibition test for L3 from 541 
individual equids in each population.  IVM: ivermectin, R: resistant, S: sensitive. A: IVM 542 
FECR < 95%, B: IVM FECR <95%, C: reduced strongyle egg reappearance period after 543 
IVM and MOX treatment, D: IVM FECRT >95%, E: IVM not administered in previous two 544 
years, F: IVM never administered.  Resistance ratios were generated by dividing the EC50 545 
estimate for each population (using all dose response data) by the EC50 estimate for 546 
Population F. 547 
 548 
Population  
IVM 
sensitivity 
status 
EC50 range (µg/ml) 
obtained using L3 
from individual 
equids 
 
EC50 (µg/ml) estimate for 
each population using all 
dose response data for each 
to fit a single best curve: 
[95% upper and lower 
confidence intervals] 
Resistance 
ratio  
 
A 
IVM-R 
3.07-13.19 
 
6.24 
[8.66, 3.81] 
56.7 
B 
IVM-R 
1.33 - 6.14 
 
 2.31 
[2.98, 1.65] 
21.0 
C 
ML-RERP 
0.48 - 2.30 
 
1.28 
[1.60, 0.96] 
11.6 
D 
IVM-S 
0.06 - 0.26 
 
0.11 
[0.13, 0.08] 
1.0 
E 
IVM-S 
0.15-0.48 
 
0.25 
[0.33, 0.16] 
2.3 
F 
IVM-S 
0.09-0.14 
 
0.11 
[0.15, 0.07] 
- 
 549 
 550 
 551 
 552 
 553 
 554 
 555 
 556 
 557 
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Legends to figures 559 
 560 
Figure 1.  Dose response curves (% migration against concentration [log 561 
10(concentration+0.01] in µg/ml) generated for each population (A-F) in the larval migration 562 
inhibition test.  A: IVM-R, B: IVM-R, C: ML-RERP, D: IVM-S, E: IVM-S, F: IVM-S. 563 
 564 
Figure 2.  Box plots of derived EC50 values from the ivermectin larval migration inhibition 565 
test using L3 from equine populations grouped as harbouring cyathostomins that were 566 
ivermectin resistant as assessed by FECRT (IVM-R), displayed a reduced strongyle egg 567 
reappearance period post ivermectin treatment (IVM-RERP) or were sensitive to ivermectin 568 
as assessed by FECRT or had limited or no treatments of ivermectin in the preceding decade 569 
(IVM-S).    570 
 571 
Figure 3. Comparison of EC50 values obtained using L3 from those individuals for which 572 
ivermectin faecal egg count reduction test analysis had been performed.  Individual equids 573 
are separated into two groups: those for which a faecal egg count reduction of <95% (upper 574 
chart) was recorded and those for which a faecal egg count reduction of >95% (lower chart) 575 
had been obtained.  Note that there was variation within populations in the level of 576 
ivermectin faecal egg count reduction when the test was applied and hence one individual 577 
from Population A (IVM-R) had an ivermectin faecal egg count reduction of > 95%.  The y-578 
axis shows the frequency of individuals over the range of EC50 values that were measured.  579 
The x-axis depicts the EC50 value obtained using L3 from individual equids.  580 
 581 
Figure 4. Percentage migration of L3 in the larval migration inhibition test, comparing time 582 
since last ivermectin administration for larvae derived from Populations A, B and C.  The 583 
 25 
mean EC50 value obtained at each log concentration for each set of time to sample data is 584 
shown. 585 
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